-
Animal & Veterinary
-
Glossary of Adverse Drug Experience (ADE) Terms
Number of Animals Evaluated
Total number of animals reported to the FDA for evaluation.
NOTE: After analyzing the reports, CVM veterinarians may determine that some of the potential adverse experiences in the animal were not possibly, probably, or definitely drug related. Therefore, these ADEs are not included in the Cumulative Adverse Drug Experiences (ADE) Summaries Report.
Sign
Description of reported adverse experience or clinical manifestation associated with drug use.
Missing
The ADE report did not indicate the route of administration.
Unknown
The ADE report states that the route of administration is unknown.
Extra-Label or Off-label
The use of an approved drug in a manner that is not in accordance with the approved label directions. For example, a product is used for indications or species for which it is not approved.
Abbreviation Definition
| ABN | ABNORMAL |
| A/G | ALBUMIN/GLOBULIN RATIO |
| ADE | ADVERSE DRUG EXPERIENCE |
| ADM | ADMINISTRATION |
| ALK PHOS | ALKALINE PHOSPHATASE |
| ALT | ALANINE AMINOTRANSFERASE |
| ANESTH | ANESTHESIA; ANESTHETIC |
| APP | APPLICATION |
| AST | ASPARTITIE AMINOTRANSFERASE |
| BANDS | NEUTROPHILS (BANDS) |
| BASOS | BASOPHILS |
| BLD | BLOOD OUTSIDE THE VASCULAR SYSTEM (E.G., HEMORRHAGE OR BLOOD USED IN TESTS) |
| BSP | BROMSULPHALEIN |
| BUN | BLOOD UREA NITROGEN |
| CA | CALCIUM |
| CHE | CHOLINESTERASE |
| CM | CLINICAL MANIFESTATION (SIGN) |
| CMP | CONCOMITANT MEDICAL PROBLEM |
| CMT | CALIFORNIA MASTITIS TEST |
| CNS | CENTRAL NERVOUS SYSTEM |
| CO2 | CARBON DIOXIDE |
| CPK | CREATINE PHOSPHOKINASE |
| CPR | CARDIOPULMONARY RESUSCITATION |
| CSF | CEREBROSPINAL FLUID |
| CTX | CONCOMITANT TREATMENT |
| DD | NUMBER OF DEAD ANIMALS |
| DDX | DIFFERENTIAL DIAGNOSIS |
| DECHALL | THE EFFECT AFTER DISCONTINUING DRUG USE |
| DIC | DISSEMINATED INTRAVASCULAR COAGULATION |
| DIR | DIRECT; CONJUGATED |
| DX | DIAGNOSIS |
| DZ | DISEASE |
| ELU | EXTRA LABEL USE OF THE DRUG |
| EOS | EOSINOPHILS |
| FE | IRON |
| F/U | FOLLOW-UP REPORT |
| GGT | GAMMA GLUTAMYL TRANSFERASE |
| GI | GASTROINTESTINAL |
| HCO3 | BICARBONATE |
| HI | HIGH, INCREASED |
| HW | HEARTWORM(S) |
| HX, H/O | HISTORY OF |
| IND | INDIRECT; UNCONJUGATED |
| INEFFECT | LACK OF OR DECREASED EFFECTIVENESS |
| INFECT | INFECTION; INFECTED |
| INFLAM | INFLAMMATION; INFLAMED |
| INJ | INJECTION; INJECT |
| INTEST | INTESTINE |
| IVF | INTRAVENOUS FLUID |
| K | POTASSIUM |
| KCS | KERATOCONJUNCTIVITIS SICCA |
| LAB | LABWORK; RESULTS OF CHC/CHEMISTRIES/CULTURE RESULTS/ ULTRASOUND/RADIOGRAPHS |
| LDH | LACTIC DEHYDROGENASE |
| LN | LYMPH NODE(S) |
| LO | LOW; DECREASED |
| LRS | LACTATED RINGERS SOLUTION |
| LYMPHS | LYMPHOCYTES |
| MG | MAMMARY GLAND |
| MGT | MAMMARY GLAND TUMOR |
| MF | MICROFILARIA |
| MONOS | MONOCYTES |
| MULT | MULTIPLE |
| NA | SODIUM |
| NEG | NEGATIVE |
| NSF | NO SIGNIFICANT FINDINGS |
| O/S | ONSET |
| P | PHOSPHORUS |
| PARENTERAL | NOT VIA THE DIGESTIVE TRACT (INCLUDES INTRAMUSCULAR, INTRAVENOUS, AND SUBCUTANEOUS INJECTION) |
| PD | PRODUCT DEFECT |
| PLATES | PLATELETS |
| PMNS | SEGMENTED NEUTROPHILS |
| PMP | PREVIOUS MEDICAL PROBLEM |
| POS | POSITIVE |
| PR | PATHOLOGY REPORT; GROSS OR MICROSCOPIC PATHOLOGY INCLUDING CULTURE DATA (NEED NOT BE A FORMAL REPORT) |
| PT | PROTHROMBIN TIME |
| PTT | PARTIAL THROMBOPLASTIN TIME |
| PTX | PREVIOUS TREATMENT |
| PX | PROGNOSIS |
| RAD(S) | RADIOGRAPH(S) (X-RAYS) |
| RBC | RED BLOOD CELLS |
| RECHAL | THE EFFECT AFTER RE-INTRODUCING SUSPECT DRUG |
| RECOV | RECOVERY, RECOVERED |
| REF | REFERENCE |
| RR | NUMBER OF ANIMALS REACTING |
| RESP | RESPIRATORY |
| RTX | TREATMENT OF SUSPECTED ADVERSE DRUG REACTION |
| RX | TO PRESCRIBE/DISPENSE A PRESCRIPTION |
| RXN | REACTION |
| SAP | ALKALINE PHOSPHATASE |
| SEGS | SEGMENTED NEUTROPHILS |
| SGOT/AST | ASPARTITIE AMINOTRANSFERASE |
| SGPT/ALT | ALANINE AMINOTRANSFERASE |
| SM | SMALL |
| SPEC | SPECIFIC |
| SG | SPECIFIC GRAVITY OF FLUID (E.G. URINE) |
| SQ | SUBCUTANEOUS |
| SQF | SUBCUTANEOUS FLUID |
| TD | NUMBER OF ANIMALS TREATED |
| TECH | TECHNIQUE; TECHNICAL; TECHNICIAN |
| TEMP | TEMPORARAY |
| TMP | TREATED MEDICAL PROBLEM (REASON FOR USE OF SUSPECT DRUG) |
| TOT | TOTAL |
| TOX | TOXICITY; TOXIC |
| TPR | TEMPERATURE, PULSE, RESPIRATION |
| TX | TREATMENT |
| UA | URINALYSIS |
| UDDER | MAMMARY GLANDS OF ALL SPECIES |
| US | ULTRASOUND |
| VACC | VACCINE; VACCINATE |
| VAX | VACCINE; VACCINATE |
| WBC | WHITE BLOOD CELLS |
| WD | WITHDRAWAL TIME |
| WNL | WITHIN NORMAL LIMITS |
-
-